nach oben

Erschienen in:

01.06.2015 | Case Report

Primary Hepatic Lymphoma: Features of a Puzzling Disease

verfasst von: Magalí Chahdi Beltrame, Martín De Santibañes, Victoria Ardiles, Oscar Mazza, Juan Pekolj, Eduardo De Santibañes, Rodrigo Sánchez Clariá

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Excerpt

Primary hepatic lymphoma (PHL) is a very rare liver tumor. It is described as a lymphoma localized and limited to the liver without extrahepatic involvement [1], and represents about 0.016 % of all non-Hodgkin lymphoma cases [2]. …

Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986;110(6):553–5.PubMed

Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252–60.CrossRefPubMed

Yang X, Tan W, Yu W, Shi S, Wang Y, Zhang Y, et al. Diagnosis and surgical treatment of primary hepatic lymphoma. World J Gastroenterol. 2010;16(47):6016–9.PubMedCentralPubMed

Bouliaris K, Christodoulidis G, Koukoulis G, Mamaloudis I, Ioannou M, Bouronikou E, et al. A primary hepatic lymphoma treated with liver resection and chemotherapy. Case Rep Surg. 2014;2014:749509.PubMedCentralPubMed

Lei KI. Primary non-Hodgkin’s lymphoma of the liver. Leuk Lymphoma. 1998;29(3–4):293–9.CrossRefPubMed

Page RD, Romaguera JE, Osborne B, Medeiros LJ, Rodriguez J, North L, et al. Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer. 2001;92(8):2023–9.CrossRefPubMed

Bairey O, Blickstein D, Stark P, Prokocimer M, Nativ HM, Kirgner I, et al. Serum CA 125 as a prognostic factor in non-Hodgkin’s lymphoma. Leuk Lymphoma. 2003;44(10):1733–8.CrossRefPubMed

Gutiérrez A, Martínez-Serra J, Barceló B, Sampol A, Viñas L, González G, et al. Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value. Int J Lab Hematol. 2010;32(6 Pt 2):582–9.CrossRefPubMed

Ojha RP, Brown LM, Felini MJ, Singh KP, Thertulien R. Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma. Leuk Lymphoma. 2010;51(9):1754–7.CrossRefPubMed

10.

Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med. 1994;121(9):633–40.CrossRefPubMed

11.

Zentar A, Tarchouli M, Elkaoui H, Belhamidi MS, Ratbi MB, Bouchentouf SM, et al. Primary hepatic lymphoma. J Gastrointest Cancer. 2014;45(3):380–2.CrossRefPubMedCentralPubMed

12.

Steller EJ, van Leeuwen MS, van Hillegersberg R, Schipper ME, Rinkes IHB, Molenaar IQ. Primary lymphoma of the liver—a complex diagnosis. World J Radiol. 2012;4(2):53–7.CrossRefPubMedCentralPubMed

13.

Abelev GI, Karamova ER, Bragina EG, Andreeva NE, Kruglova GV. Immuno-isotachophoretic determination of monoclonal immunoglobulin light chains produced by neoplastic B-cells: use in diagnosis, monitoring and detection of residual disease. Int J Cancer. 1990;46(3):351–5.CrossRefPubMed

14.

Avlonitis VS, Linos D. Primary hepatic lymphoma: a review. Eur J Surg. 1999;165(8):725–9.CrossRefPubMed

15.

Takeuchi N, Naba K. Primary hepatic lymphoma is difficult to discriminate from a liver abscess. Case Rep Gastrointest Med. 2014;2014:925307.PubMedCentralPubMed

16.

Romaguera JE, Osborne B, Medeiros LJ, Rodriguez J, North L, Sanz-rodriguez C, and Cabanillas F. “Favorable Outcome after Combination Chemotherapy,” Am Cancer Soc, pp. 10–15, 1995.

17.

Mastoraki A, Stefanou MI, Chatzoglou E, Danias N, Kyriazi M, Arkadopoulos N, et al. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30(3):150–4.CrossRefPubMed

18.

Eidt S, Nebeling M, Pohl C, Siedek M. [Neoadjuvant chemotherapy of primary hepatic non-Hodgkin’s lymphoma]. Med Klin (Munich). 2003;98(2):96–9.CrossRef

19.

Noronha V, Shafi NQ, Obando JA, Kummar S. Primary non-Hodgkin’s lymphoma of the liver. Crit Rev Oncol Hematol. 2005;53(3):199–207.CrossRefPubMed

Titel: Primary Hepatic Lymphoma: Features of a Puzzling Disease
verfasst von: Magalí Chahdi Beltrame
Martín De Santibañes
Victoria Ardiles
Oscar Mazza
Juan Pekolj
Eduardo De Santibañes
Rodrigo Sánchez Clariá
Publikationsdatum: 01.06.2015
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 2/2015
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-015-9694-3

Springer Medizin

Primary Hepatic Lymphoma: Features of a Puzzling Disease

Excerpt

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Treatment of High-Grade Metastatic Pancreatic Neuroendocrine Carcinoma with FOLFIRINOX

Endoscopic Resection of Two Rare Esophageal Tumors

Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)

Status of Colorectal Cancer Devices: Present Scenario

Cases of Spontaneous Tumor Regression in Hepatobiliary Cancers: Implications for Immunotherapy?

Molecular Analysis of Iranian Colorectal Cancer Patients at Risk for Lynch Syndrome: a New Molecular, Clinicopathological Feature

Neu im Fachgebiet Onkologie

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

Update Onkologie